![Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/c1baf3ce-a0f0-4029-91ba-1d27b84f5657/gr2_lrg.jpg)
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
![Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-64068-3/MediaObjects/41598_2020_64068_Fig1_HTML.png)
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
![Frontiers | Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection Frontiers | Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection](https://www.frontiersin.org/files/MyHome%20Article%20Library/660215/660215_Thumb_400.jpg)
Frontiers | Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
![Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria | Annals of Surgical Oncology Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria | Annals of Surgical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-020-09100-6/MediaObjects/10434_2020_9100_Fig3_HTML.png)
Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria | Annals of Surgical Oncology
![The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer - Guenther - 2022 - International Journal of Cancer - Wiley Online Library The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer - Guenther - 2022 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f6c95218-65fb-4b88-9548-4bd5974b9f45/ijc34044-toc-0001-m.jpg)
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer - Guenther - 2022 - International Journal of Cancer - Wiley Online Library
![Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study | BMC Cancer | Full Text Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6690-1/MediaObjects/12885_2020_6690_Fig2_HTML.png)
Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study | BMC Cancer | Full Text
![Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram](https://www.researchgate.net/publication/320904900/figure/fig1/AS:614317649059844@1523476149163/Overall-survival-in-patients-with-pancreatic-cancer-according-to-the-four-molecular.png)
Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
![PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8faa1d8f68b65770edd2aeca36796df9f4345753/6-Figure2-1.png)
PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
![Five-year survival rates among PDAC patients with and without DM and... | Download Scientific Diagram Five-year survival rates among PDAC patients with and without DM and... | Download Scientific Diagram](https://www.researchgate.net/publication/341137444/figure/fig1/AS:960134222213136@1605925245370/Five-year-survival-rates-among-PDAC-patients-with-and-without-DM-and-non-DM-are-shown-No.png)
Five-year survival rates among PDAC patients with and without DM and... | Download Scientific Diagram
![Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma](https://www.jcancer.org/v11/p0009/jcav11p0009g001.jpg)
Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma
![Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-17743-6/MediaObjects/41598_2022_17743_Fig1_HTML.png)
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports
![Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12916-018-1120-9/MediaObjects/12916_2018_1120_Fig1_HTML.png)
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text
![JCM | Free Full-Text | C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients JCM | Free Full-Text | C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients](https://www.mdpi.com/jcm/jcm-08-01791/article_deploy/html/images/jcm-08-01791-g001-550.jpg)
JCM | Free Full-Text | C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients
![Cancers | Free Full-Text | Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy Cancers | Free Full-Text | Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy](https://pub.mdpi-res.com/cancers/cancers-15-02608/article_deploy/html/images/cancers-15-02608-g001-550.jpg?1683194929)
Cancers | Free Full-Text | Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data | PLOS ONE
![Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy](https://www.spandidos-publications.com/article_images/or/42/5/or-42-05-1856-g03.jpg)
Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
![Pancreatic cancer: a glimmer of hope - Nagendram - 2023 - Trends in Urology & Men's Health - Wiley Online Library Pancreatic cancer: a glimmer of hope - Nagendram - 2023 - Trends in Urology & Men's Health - Wiley Online Library](https://wchh.onlinelibrary.wiley.com/cms/asset/435cf87c-5b00-4f2e-9995-9cfdf71c0650/tre904-fig-0001-m.jpg)